Global Veterinary Biologics Market Insights, Forecast to 2034
Veterinary biologics are vaccines, antigens, antitoxins and other preparations made from living organisms (or genetically engineered) and intended for use in diagnosing, treating, or immunizing animals. Unlike some pharmaceutical products, such as antibiotics, most biologics leave no residues in animals.
Global Veterinary Biologics market is expected to reach to US$ 11540 million in 2024, with a positive growth of %, compared with US$ 10810 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Veterinary Biologics industry is evaluated to reach US$ 17220 million in 2029. The CAGR will be 6.9% during 2024 to 2029.
The Animal Healthcare market is primarily driven by the increasing awareness about animal health and well-being, coupled with the rising prevalence of various animal diseases. Pet ownership has grown, leading to higher demand for veterinary services and products. Additionally, the growth of the livestock industry to meet global food demand further boosts the need for animal healthcare products. Advances in veterinary medicine and technology are also driving market growth, enabling better diagnosis, treatment, and preventive care for animals. However, challenges include regulatory complexities and the high cost of certain treatments, which can hinder accessibility for some pet owners or farmers. Striking a balance between quality care and affordability is crucial for the sustainable growth of the animal healthcare market.
Report Covers
This report presents an overview of global Veterinary Biologics market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Veterinary Biologics market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco/Eli Lilly
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken
FATRO
Vaksindo
Bio-Labs
Avimex Animal
Segment by Type
Vaccines
Monoclonal Antibodies
Segment by Application
Llivestock
Equine
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Veterinary Biologics plant distribution, commercial date of Veterinary Biologics, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Veterinary Biologics introduction, etc. Veterinary Biologics Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Veterinary Biologics
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Table of Content
1 Study Coverage
1.1 Veterinary Biologics Product Introduction
1.2 Market by Type
1.2.1 Global Veterinary Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Vaccines
1.2.3 Monoclonal Antibodies
1.3 Market by Application
1.3.1 Global Veterinary Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Llivestock
1.3.3 Equine
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Veterinary Biologics Sales Estimates and Forecasts 2018-2029
2.2 Global Veterinary Biologics Revenue by Region
2.2.1 Global Veterinary Biologics Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Veterinary Biologics Revenue by Region (2018-2024)
2.2.3 Global Veterinary Biologics Revenue by Region (2024-2029)
2.2.4 Global Veterinary Biologics Revenue Market Share by Region (2018-2029)
2.3 Global Veterinary Biologics Sales Estimates and Forecasts 2018-2029
2.4 Global Veterinary Biologics Sales by Region
2.4.1 Global Veterinary Biologics Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Veterinary Biologics Sales by Region (2018-2024)
2.4.3 Global Veterinary Biologics Sales by Region (2024-2029)
2.4.4 Global Veterinary Biologics Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Veterinary Biologics Sales by Manufacturers
3.1.1 Global Veterinary Biologics Sales by Manufacturers (2018-2024)
3.1.2 Global Veterinary Biologics Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Veterinary Biologics in 2022
3.2 Global Veterinary Biologics Revenue by Manufacturers
3.2.1 Global Veterinary Biologics Revenue by Manufacturers (2018-2024)
3.2.2 Global Veterinary Biologics Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Veterinary Biologics Revenue in 2022
3.3 Global Key Players of Veterinary Biologics, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Veterinary Biologics Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Veterinary Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Veterinary Biologics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Veterinary Biologics, Product Offered and Application
3.8 Global Key Manufacturers of Veterinary Biologics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Veterinary Biologics Sales by Type
4.1.1 Global Veterinary Biologics Historical Sales by Type (2018-2024)
4.1.2 Global Veterinary Biologics Forecasted Sales by Type (2024-2029)
4.1.3 Global Veterinary Biologics Sales Market Share by Type (2018-2029)
4.2 Global Veterinary Biologics Revenue by Type
4.2.1 Global Veterinary Biologics Historical Revenue by Type (2018-2024)
4.2.2 Global Veterinary Biologics Forecasted Revenue by Type (2024-2029)
4.2.3 Global Veterinary Biologics Revenue Market Share by Type (2018-2029)
4.3 Global Veterinary Biologics Price by Type
4.3.1 Global Veterinary Biologics Price by Type (2018-2024)
4.3.2 Global Veterinary Biologics Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Veterinary Biologics Sales by Application
5.1.1 Global Veterinary Biologics Historical Sales by Application (2018-2024)
5.1.2 Global Veterinary Biologics Forecasted Sales by Application (2024-2029)
5.1.3 Global Veterinary Biologics Sales Market Share by Application (2018-2029)
5.2 Global Veterinary Biologics Revenue by Application
5.2.1 Global Veterinary Biologics Historical Revenue by Application (2018-2024)
5.2.2 Global Veterinary Biologics Forecasted Revenue by Application (2024-2029)
5.2.3 Global Veterinary Biologics Revenue Market Share by Application (2018-2029)
5.3 Global Veterinary Biologics Price by Application
5.3.1 Global Veterinary Biologics Price by Application (2018-2024)
5.3.2 Global Veterinary Biologics Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Veterinary Biologics Market Size by Type
6.1.1 US & Canada Veterinary Biologics Sales by Type (2018-2029)
6.1.2 US & Canada Veterinary Biologics Revenue by Type (2018-2029)
6.2 US & Canada Veterinary Biologics Market Size by Application
6.2.1 US & Canada Veterinary Biologics Sales by Application (2018-2029)
6.2.2 US & Canada Veterinary Biologics Revenue by Application (2018-2029)
6.3 US & Canada Veterinary Biologics Market Size by Country
6.3.1 US & Canada Veterinary Biologics Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Veterinary Biologics Sales by Country (2018-2029)
6.3.3 US & Canada Veterinary Biologics Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Veterinary Biologics Market Size by Type
7.1.1 Europe Veterinary Biologics Sales by Type (2018-2029)
7.1.2 Europe Veterinary Biologics Revenue by Type (2018-2029)
7.2 Europe Veterinary Biologics Market Size by Application
7.2.1 Europe Veterinary Biologics Sales by Application (2018-2029)
7.2.2 Europe Veterinary Biologics Revenue by Application (2018-2029)
7.3 Europe Veterinary Biologics Market Size by Country
7.3.1 Europe Veterinary Biologics Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Veterinary Biologics Sales by Country (2018-2029)
7.3.3 Europe Veterinary Biologics Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Veterinary Biologics Market Size
8.1.1 China Veterinary Biologics Sales (2018-2029)
8.1.2 China Veterinary Biologics Revenue (2018-2029)
8.2 China Veterinary Biologics Market Size by Application
8.2.1 China Veterinary Biologics Sales by Application (2018-2029)
8.2.2 China Veterinary Biologics Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Veterinary Biologics Market Size by Type
9.1.1 Asia Veterinary Biologics Sales by Type (2018-2029)
9.1.2 Asia Veterinary Biologics Revenue by Type (2018-2029)
9.2 Asia Veterinary Biologics Market Size by Application
9.2.1 Asia Veterinary Biologics Sales by Application (2018-2029)
9.2.2 Asia Veterinary Biologics Revenue by Application (2018-2029)
9.3 Asia Veterinary Biologics Sales by Region
9.3.1 Asia Veterinary Biologics Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Veterinary Biologics Revenue by Region (2018-2029)
9.3.3 Asia Veterinary Biologics Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Veterinary Biologics Market Size by Type
10.1.1 Middle East, Africa and Latin America Veterinary Biologics Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Veterinary Biologics Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Veterinary Biologics Market Size by Application
10.2.1 Middle East, Africa and Latin America Veterinary Biologics Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Veterinary Biologics Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Veterinary Biologics Sales by Country
10.3.1 Middle East, Africa and Latin America Veterinary Biologics Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Veterinary Biologics Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Veterinary Biologics Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Merck Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Zoetis
11.2.1 Zoetis Company Information
11.2.2 Zoetis Overview
11.2.3 Zoetis Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Zoetis Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Zoetis Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Boehringer Ingelheim Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Ceva
11.4.1 Ceva Company Information
11.4.2 Ceva Overview
11.4.3 Ceva Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Ceva Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ceva Recent Developments
11.5 CAHIC
11.5.1 CAHIC Company Information
11.5.2 CAHIC Overview
11.5.3 CAHIC Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 CAHIC Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CAHIC Recent Developments
11.6 HVRI
11.6.1 HVRI Company Information
11.6.2 HVRI Overview
11.6.3 HVRI Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 HVRI Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 HVRI Recent Developments
11.7 Ringpu Biology
11.7.1 Ringpu Biology Company Information
11.7.2 Ringpu Biology Overview
11.7.3 Ringpu Biology Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Ringpu Biology Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ringpu Biology Recent Developments
11.8 Yebio
11.8.1 Yebio Company Information
11.8.2 Yebio Overview
11.8.3 Yebio Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Yebio Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Yebio Recent Developments
11.9 DHN
11.9.1 DHN Company Information
11.9.2 DHN Overview
11.9.3 DHN Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 DHN Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 DHN Recent Developments
11.10 WINSUN
11.10.1 WINSUN Company Information
11.10.2 WINSUN Overview
11.10.3 WINSUN Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 WINSUN Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 WINSUN Recent Developments
11.11 Elanco/Eli Lilly
11.11.1 Elanco/Eli Lilly Company Information
11.11.2 Elanco/Eli Lilly Overview
11.11.3 Elanco/Eli Lilly Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Elanco/Eli Lilly Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Elanco/Eli Lilly Recent Developments
11.12 Virbac
11.12.1 Virbac Company Information
11.12.2 Virbac Overview
11.12.3 Virbac Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Virbac Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Virbac Recent Developments
11.13 Jinyu Bio-Technology
11.13.1 Jinyu Bio-Technology Company Information
11.13.2 Jinyu Bio-Technology Overview
11.13.3 Jinyu Bio-Technology Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Jinyu Bio-Technology Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Jinyu Bio-Technology Recent Developments
11.14 ChengDu Tecbond
11.14.1 ChengDu Tecbond Company Information
11.14.2 ChengDu Tecbond Overview
11.14.3 ChengDu Tecbond Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 ChengDu Tecbond Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 ChengDu Tecbond Recent Developments
11.15 CAVAC
11.15.1 CAVAC Company Information
11.15.2 CAVAC Overview
11.15.3 CAVAC Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 CAVAC Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 CAVAC Recent Developments
11.16 Kyoto Biken
11.16.1 Kyoto Biken Company Information
11.16.2 Kyoto Biken Overview
11.16.3 Kyoto Biken Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Kyoto Biken Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Kyoto Biken Recent Developments
11.17 FATRO
11.17.1 FATRO Company Information
11.17.2 FATRO Overview
11.17.3 FATRO Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 FATRO Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 FATRO Recent Developments
11.18 Vaksindo
11.18.1 Vaksindo Company Information
11.18.2 Vaksindo Overview
11.18.3 Vaksindo Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Vaksindo Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Vaksindo Recent Developments
11.19 Bio-Labs
11.19.1 Bio-Labs Company Information
11.19.2 Bio-Labs Overview
11.19.3 Bio-Labs Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Bio-Labs Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Bio-Labs Recent Developments
11.20 Avimex Animal
11.20.1 Avimex Animal Company Information
11.20.2 Avimex Animal Overview
11.20.3 Avimex Animal Veterinary Biologics Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 Avimex Animal Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Avimex Animal Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Veterinary Biologics Industry Chain Analysis
12.2 Veterinary Biologics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Veterinary Biologics Production Mode & Process
12.4 Veterinary Biologics Sales and Marketing
12.4.1 Veterinary Biologics Sales Channels
12.4.2 Veterinary Biologics Distributors
12.5 Veterinary Biologics Customers
13 Market Dynamics
13.1 Veterinary Biologics Industry Trends
13.2 Veterinary Biologics Market Drivers
13.3 Veterinary Biologics Market Challenges
13.4 Veterinary Biologics Market Restraints
14 Key Findings in The Global Veterinary Biologics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figure
List of Tables
Table 1. Global Veterinary Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Vaccines
Table 3. Major Manufacturers of Monoclonal Antibodies
Table 4. Global Veterinary Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Veterinary Biologics Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Veterinary Biologics Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Veterinary Biologics Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Veterinary Biologics Revenue Market Share by Region (2018-2024)
Table 9. Global Veterinary Biologics Revenue Market Share by Region (2024-2029)
Table 10. Global Veterinary Biologics Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Veterinary Biologics Sales by Region (2018-2024) & (M Units)
Table 12. Global Veterinary Biologics Sales by Region (2024-2029) & (M Units)
Table 13. Global Veterinary Biologics Sales Market Share by Region (2018-2024)
Table 14. Global Veterinary Biologics Sales Market Share by Region (2024-2029)
Table 15. Global Veterinary Biologics Sales by Manufacturers (2018-2024) & (M Units)
Table 16. Global Veterinary Biologics Sales Share by Manufacturers (2018-2024)
Table 17. Global Veterinary Biologics Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Veterinary Biologics Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Veterinary Biologics, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Veterinary Biologics Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Veterinary Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Veterinary Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Biologics as of 2022)
Table 23. Global Key Manufacturers of Veterinary Biologics, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Veterinary Biologics, Product Offered and Application
Table 25. Global Key Manufacturers of Veterinary Biologics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Veterinary Biologics Sales by Type (2018-2024) & (M Units)
Table 28. Global Veterinary Biologics Sales by Type (2024-2029) & (M Units)
Table 29. Global Veterinary Biologics Sales Share by Type (2018-2024)
Table 30. Global Veterinary Biologics Sales Share by Type (2024-2029)
Table 31. Global Veterinary Biologics Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Veterinary Biologics Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Veterinary Biologics Revenue Share by Type (2018-2024)
Table 34. Global Veterinary Biologics Revenue Share by Type (2024-2029)
Table 35. Veterinary Biologics Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Veterinary Biologics Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Veterinary Biologics Sales by Application (2018-2024) & (M Units)
Table 38. Global Veterinary Biologics Sales by Application (2024-2029) & (M Units)
Table 39. Global Veterinary Biologics Sales Share by Application (2018-2024)
Table 40. Global Veterinary Biologics Sales Share by Application (2024-2029)
Table 41. Global Veterinary Biologics Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Veterinary Biologics Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Veterinary Biologics Revenue Share by Application (2018-2024)
Table 44. Global Veterinary Biologics Revenue Share by Application (2024-2029)
Table 45. Veterinary Biologics Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Veterinary Biologics Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Veterinary Biologics Sales by Type (2018-2024) & (M Units)
Table 48. US & Canada Veterinary Biologics Sales by Type (2024-2029) & (M Units)
Table 49. US & Canada Veterinary Biologics Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Veterinary Biologics Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Veterinary Biologics Sales by Application (2018-2024) & (M Units)
Table 52. US & Canada Veterinary Biologics Sales by Application (2024-2029) & (M Units)
Table 53. US & Canada Veterinary Biologics Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Veterinary Biologics Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Veterinary Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Veterinary Biologics Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Veterinary Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Veterinary Biologics Sales by Country (2018-2024) & (M Units)
Table 59. US & Canada Veterinary Biologics Sales by Country (2024-2029) & (M Units)
Table 60. Europe Veterinary Biologics Sales by Type (2018-2024) & (M Units)
Table 61. Europe Veterinary Biologics Sales by Type (2024-2029) & (M Units)
Table 62. Europe Veterinary Biologics Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Veterinary Biologics Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Veterinary Biologics Sales by Application (2018-2024) & (M Units)
Table 65. Europe Veterinary Biologics Sales by Application (2024-2029) & (M Units)
Table 66. Europe Veterinary Biologics Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Veterinary Biologics Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Veterinary Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Veterinary Biologics Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Veterinary Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Veterinary Biologics Sales by Country (2018-2024) & (M Units)
Table 72. Europe Veterinary Biologics Sales by Country (2024-2029) & (M Units)
Table 73. China Veterinary Biologics Sales by Type (2018-2024) & (M Units)
Table 74. China Veterinary Biologics Sales by Type (2024-2029) & (M Units)
Table 75. China Veterinary Biologics Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Veterinary Biologics Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Veterinary Biologics Sales by Application (2018-2024) & (M Units)
Table 78. China Veterinary Biologics Sales by Application (2024-2029) & (M Units)
Table 79. China Veterinary Biologics Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Veterinary Biologics Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Veterinary Biologics Sales by Type (2018-2024) & (M Units)
Table 82. Asia Veterinary Biologics Sales by Type (2024-2029) & (M Units)
Table 83. Asia Veterinary Biologics Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Veterinary Biologics Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Veterinary Biologics Sales by Application (2018-2024) & (M Units)
Table 86. Asia Veterinary Biologics Sales by Application (2024-2029) & (M Units)
Table 87. Asia Veterinary Biologics Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Veterinary Biologics Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Veterinary Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Veterinary Biologics Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Veterinary Biologics Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Veterinary Biologics Sales by Region (2018-2024) & (M Units)
Table 93. Asia Veterinary Biologics Sales by Region (2024-2029) & (M Units)
Table 94. Middle East, Africa and Latin America Veterinary Biologics Sales by Type (2018-2024) & (M Units)
Table 95. Middle East, Africa and Latin America Veterinary Biologics Sales by Type (2024-2029) & (M Units)
Table 96. Middle East, Africa and Latin America Veterinary Biologics Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Veterinary Biologics Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Veterinary Biologics Sales by Application (2018-2024) & (M Units)
Table 99. Middle East, Africa and Latin America Veterinary Biologics Sales by Application (2024-2029) & (M Units)
Table 100. Middle East, Africa and Latin America Veterinary Biologics Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Veterinary Biologics Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Veterinary Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Veterinary Biologics Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Veterinary Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Veterinary Biologics Sales by Country (2018-2024) & (M Units)
Table 106. Middle East, Africa and Latin America Veterinary Biologics Sales by Country (2024-2029) & (M Units)
Table 107. Merck Company Information
Table 108. Merck Description and Major Businesses
Table 109. Merck Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Merck Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Merck Recent Developments
Table 112. Zoetis Company Information
Table 113. Zoetis Description and Major Businesses
Table 114. Zoetis Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Zoetis Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Zoetis Recent Developments
Table 117. Boehringer Ingelheim Company Information
Table 118. Boehringer Ingelheim Description and Major Businesses
Table 119. Boehringer Ingelheim Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Boehringer Ingelheim Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Boehringer Ingelheim Recent Developments
Table 122. Ceva Company Information
Table 123. Ceva Description and Major Businesses
Table 124. Ceva Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Ceva Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Ceva Recent Developments
Table 127. CAHIC Company Information
Table 128. CAHIC Description and Major Businesses
Table 129. CAHIC Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. CAHIC Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. CAHIC Recent Developments
Table 132. HVRI Company Information
Table 133. HVRI Description and Major Businesses
Table 134. HVRI Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. HVRI Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. HVRI Recent Developments
Table 137. Ringpu Biology Company Information
Table 138. Ringpu Biology Description and Major Businesses
Table 139. Ringpu Biology Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Ringpu Biology Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Ringpu Biology Recent Developments
Table 142. Yebio Company Information
Table 143. Yebio Description and Major Businesses
Table 144. Yebio Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Yebio Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Yebio Recent Developments
Table 147. DHN Company Information
Table 148. DHN Description and Major Businesses
Table 149. DHN Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. DHN Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. DHN Recent Developments
Table 152. WINSUN Company Information
Table 153. WINSUN Description and Major Businesses
Table 154. WINSUN Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. WINSUN Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. WINSUN Recent Developments
Table 157. Elanco/Eli Lilly Company Information
Table 158. Elanco/Eli Lilly Description and Major Businesses
Table 159. Elanco/Eli Lilly Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Elanco/Eli Lilly Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Elanco/Eli Lilly Recent Developments
Table 162. Virbac Company Information
Table 163. Virbac Description and Major Businesses
Table 164. Virbac Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Virbac Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Virbac Recent Developments
Table 167. Jinyu Bio-Technology Company Information
Table 168. Jinyu Bio-Technology Description and Major Businesses
Table 169. Jinyu Bio-Technology Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Jinyu Bio-Technology Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Jinyu Bio-Technology Recent Developments
Table 172. ChengDu Tecbond Company Information
Table 173. ChengDu Tecbond Description and Major Businesses
Table 174. ChengDu Tecbond Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. ChengDu Tecbond Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. ChengDu Tecbond Recent Developments
Table 177. CAVAC Company Information
Table 178. CAVAC Description and Major Businesses
Table 179. CAVAC Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. CAVAC Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. CAVAC Recent Developments
Table 182. Kyoto Biken Company Information
Table 183. Kyoto Biken Description and Major Businesses
Table 184. Kyoto Biken Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 185. Kyoto Biken Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Kyoto Biken Recent Developments
Table 187. FATRO Company Information
Table 188. FATRO Description and Major Businesses
Table 189. FATRO Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 190. FATRO Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. FATRO Recent Developments
Table 192. Vaksindo Company Information
Table 193. Vaksindo Description and Major Businesses
Table 194. Vaksindo Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 195. Vaksindo Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Vaksindo Recent Developments
Table 197. Bio-Labs Company Information
Table 198. Bio-Labs Description and Major Businesses
Table 199. Bio-Labs Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 200. Bio-Labs Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Bio-Labs Recent Developments
Table 202. Avimex Animal Company Information
Table 203. Avimex Animal Description and Major Businesses
Table 204. Avimex Animal Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 205. Avimex Animal Veterinary Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. Avimex Animal Recent Developments
Table 207. Key Raw Materials Lists
Table 208. Raw Materials Key Suppliers Lists
Table 209. Veterinary Biologics Distributors List
Table 210. Veterinary Biologics Customers List
Table 211. Veterinary Biologics Market Trends
Table 212. Veterinary Biologics Market Drivers
Table 213. Veterinary Biologics Market Challenges
Table 214. Veterinary Biologics Market Restraints
Table 215. Research Programs/Design for This Report
Table 216. Key Data Information from Secondary Sources
Table 217. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary Biologics Product Picture
Figure 2. Global Veterinary Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Veterinary Biologics Market Share by Type in 2022 & 2029
Figure 4. Vaccines Product Picture
Figure 5. Monoclonal Antibodies Product Picture
Figure 6. Global Veterinary Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Veterinary Biologics Market Share by Application in 2022 & 2029
Figure 8. Llivestock
Figure 9. Equine
Figure 10. Other
Figure 11. Veterinary Biologics Report Years Considered
Figure 12. Global Veterinary Biologics Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Veterinary Biologics Revenue 2018-2029 (US$ Million)
Figure 14. Global Veterinary Biologics Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Veterinary Biologics Revenue Market Share by Region (2018-2029)
Figure 16. Global Veterinary Biologics Sales 2018-2029 ((M Units)
Figure 17. Global Veterinary Biologics Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Veterinary Biologics Sales YoY (2018-2029) & (M Units)
Figure 19. US & Canada Veterinary Biologics Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Veterinary Biologics Sales YoY (2018-2029) & (M Units)
Figure 21. Europe Veterinary Biologics Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Veterinary Biologics Sales YoY (2018-2029) & (M Units)
Figure 23. China Veterinary Biologics Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Veterinary Biologics Sales YoY (2018-2029) & (M Units)
Figure 25. Asia (excluding China) Veterinary Biologics Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Veterinary Biologics Sales YoY (2018-2029) & (M Units)
Figure 27. Middle East, Africa and Latin America Veterinary Biologics Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Veterinary Biologics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Veterinary Biologics in the World: Market Share by Veterinary Biologics Revenue in 2022
Figure 30. Global Veterinary Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Veterinary Biologics Sales Market Share by Type (2018-2029)
Figure 32. Global Veterinary Biologics Revenue Market Share by Type (2018-2029)
Figure 33. Global Veterinary Biologics Sales Market Share by Application (2018-2029)
Figure 34. Global Veterinary Biologics Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Veterinary Biologics Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Veterinary Biologics Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Veterinary Biologics Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Veterinary Biologics Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Veterinary Biologics Revenue Share by Country (2018-2029)
Figure 40. US & Canada Veterinary Biologics Sales Share by Country (2018-2029)
Figure 41. U.S. Veterinary Biologics Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Veterinary Biologics Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Veterinary Biologics Sales Market Share by Type (2018-2029)
Figure 44. Europe Veterinary Biologics Revenue Market Share by Type (2018-2029)
Figure 45. Europe Veterinary Biologics Sales Market Share by Application (2018-2029)
Figure 46. Europe Veterinary Biologics Revenue Market Share by Application (2018-2029)
Figure 47. Europe Veterinary Biologics Revenue Share by Country (2018-2029)
Figure 48. Europe Veterinary Biologics Sales Share by Country (2018-2029)
Figure 49. Germany Veterinary Biologics Revenue (2018-2029) & (US$ Million)
Figure 50. France Veterinary Biologics Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Veterinary Biologics Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Veterinary Biologics Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Veterinary Biologics Revenue (2018-2029) & (US$ Million)
Figure 54. China Veterinary Biologics Sales Market Share by Type (2018-2029)
Figure 55. China Veterinary Biologics Revenue Market Share by Type (2018-2029)
Figure 56. China Veterinary Biologics Sales Market Share by Application (2018-2029)
Figure 57. China Veterinary Biologics Revenue Market Share by Application (2018-2029)
Figure 58. Asia Veterinary Biologics Sales Market Share by Type (2018-2029)
Figure 59. Asia Veterinary Biologics Revenue Market Share by Type (2018-2029)
Figure 60. Asia Veterinary Biologics Sales Market Share by Application (2018-2029)
Figure 61. Asia Veterinary Biologics Revenue Market Share by Application (2018-2029)
Figure 62. Asia Veterinary Biologics Revenue Share by Region (2018-2029)
Figure 63. Asia Veterinary Biologics Sales Share by Region (2018-2029)
Figure 64. Japan Veterinary Biologics Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Veterinary Biologics Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Veterinary Biologics Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Veterinary Biologics Revenue (2018-2029) & (US$ Million)
Figure 68. India Veterinary Biologics Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Veterinary Biologics Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Veterinary Biologics Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Veterinary Biologics Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Veterinary Biologics Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Veterinary Biologics Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Veterinary Biologics Sales Share by Country (2018-2029)
Figure 75. Brazil Veterinary Biologics Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Veterinary Biologics Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Veterinary Biologics Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Veterinary Biologics Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Veterinary Biologics Revenue (2018-2029) & (US$ Million)
Figure 80. Veterinary Biologics Value Chain
Figure 81. Veterinary Biologics Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed